 |
 |

Rapid Fluorescent Screening Test for Skin Malignancy
MORRIS J. LIPNIK, MD
Arch Dermatol. 1963;87(5):575-583.
Abstract
 |  |
Preliminary results are outlined of a fluorescent test for the screening of skin tumors. Tumors are tested by application of a 1% demethylchlortetracycline (Declomycin)-0.1% cyanocobalamin (vitamin B12) solution while under observation with the Wood's light (black light). A bright yellow-green fluorescence will be noted in tumors painted with the demethylchlortetracycline-cyanocobalamin solution. A challenge solution of 4.9% trichloracetic acid is then applied to the fluorescent area. If the test is negative, the green fluorescence disappears. If the test is positive, yellow-green fluorescence must remain within crusts and granules of the tumor through a ten-second test period. Of a large variety of tumors tested, basal cell epitheliomas, squamous cell carcinomas, Bowen's disease (squamous cell carcinoma in situ), and certain senile keratoses were found to show a positive test. In screening these malignant and premalignant tumors, 68 of 75 tumors tested gave a positive test. Of 191 benign tumors tested, 186 showed a negative test.
Author Affiliations
DETROIT
From the Department of Medicine, Sinai Hospital of Detroit, Section of Dermatology.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Fluorescent Test for Skin Malignancy
BURROWS
Arch Dermatol 1964;90:411-411.
ABSTRACT
|